Here’s what Head of Performance Media Josh Palau had to say about how Pfizer currently navigates the CTV landscape, including why having your own hands-on-keyboard experts is key and how new ad formats can be slow to accommodate pharmaceutical brands.
The post Why Pfizer’s Josh Palau Can’t Wait To Buy Netflix Through The Yahoo DSP appeared first on AdExchanger.
More Stories
Is Netflix In a Slump? Here’s What Its Q2 Earnings Suggest
The Real Convergence Story Is Happening in Local Markets
BusinessDesk and Range Rover bring back the CEO Index